Gender difference for cardiac care
Women treated for severe heart attacks are less often than men to receive coronary angioplasty treatment according to a Linköping University study presented in Paris at the on-going European Society of Cardiology Congress (ESC).
They examined data from more than 30,000 patients and compared treatment dispensed over a decade. In the 90s, clot-dissolving agents were the dominant treatment, which more often caused side effects, such as bleeding, in women. Therefore, fewer women than men received the treatment.
During early 2000s a different approach took hold, namely dilation of the blocked blood vessel using surgical balloons, which causes less side effects. Nevertheless, the Linköping study indicates that a gender gap still exists: compared with men, 20 % fewer women received this treatment.
Even post-operative treatments displayed noticeable differences for medication of men and women.
Text: Åke Hjelm
Last updated: 2012-12-10